SPIKE Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jul 13, 2021)
Stopping the Pharmaceutical Industry from Keeping drugs Expensive Act or the SPIKE Act
This bill requires the Centers for Medicare & Medicaid Services (CMS) to determine at least annually whether certain covered drugs under Medicare were subject to a price increase that exceeded specified thresholds. Drug manufacturers must submit justifications for such price increases to the CMS, subject to civil penalties. The bill's requirements do not apply to low-cost drugs, as identified by the CMS.
What just happenedJul 14, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJul 13, 2021
- Jul 14, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 13, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 13, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Jul 13, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jul 13, 2021IntroReferralIntro-H
Introduced in House
- Jul 13, 2021IntroReferral1000
Introduced in House